Crossmark

Toward developing a metastatic breast cancer treatment strategy that incorporates history of response to previous treatments

Published Online: 2021-03-01

Published Print: 2021-12

Authors

Olow, Aleksandra K. http://orcid.org/0000-0002-0113-8306
Veer, Laura van ’t

Wolf, Denise M.
Funding

Funding for this research was provided by:

National Cancer Institute (28XS197 P-0518835)

Breast Cancer Research Foundation

Breast Cancer Research Trust

Stand Up To Cancer

California Breast Cancer Research Program

UCSF Give Breast Cancer the Boot
License Information

Text and Data Mining valid from 2021-03-01

Version of Record valid from 2021-03-01
More Information

Article History

Received: 13 May 2020

Accepted: 15 February 2021

First Online: 1 March 2021

Ethics approval and consent to participate

: Not applicable.

: Not applicable.

: Author Aleksandra Olow is currently employed by Merck, Sharpe and Dohme Corp. Merck, Sharpe and Dohme Corp. has not been involved in funding of the presented research, nor play any role in the study design, collection, analysis, and interpretation of data, nor in writing of the manuscript.

Document is current